Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Clinical trial NCT01857323 · COMPLETED

Trial details

NCT number: NCT01857323
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Asthma Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2013-05-01
Primary completion: 2013-08-01
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.